Cargando…
Degradation kinetics of α‐conotoxin TxID
α‐Conotoxin (CTx) TxID is a potent α3β4 nicotinic acetylcholine receptor (nAChR) antagonist that has been suggested as a potential drug candidate to treat addiction and small cell lung cancer. The function and structure of TxID have been well‐studied, but analyses of its stability have not previousl...
Autores principales: | Xu, Pan, Xiong, Yang, Liu, Yiqiao, Yu, Shurun, Zhangsun, Dongting, Wu, Yong, Luo, Sulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722883/ https://www.ncbi.nlm.nih.gov/pubmed/31278882 http://dx.doi.org/10.1002/2211-5463.12697 |
Ejemplares similares
-
DSPE-PEG Modification of α-Conotoxin TxID
por: Zhao, Weinan, et al.
Publicado: (2019) -
α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice
por: Li, Xiaodan, et al.
Publicado: (2020) -
Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID
por: Dong, Jianying, et al.
Publicado: (2023) -
Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor
por: Ren, Jie, et al.
Publicado: (2018) -
Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors
por: Huang, Meiling, et al.
Publicado: (2022)